The DOI matches its Crossref record; 244 of the 244 references it cites were found in a registry or an index.
Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease
Open accessAbstract
Generating reactive oxygen species (ROS) is necessary for both physiology and pathology. An imbalance between endogenous oxidants and antioxidants causes oxidative stress, contributing to vascular dysfunction. The ROS-induced activation of transcription factors and proinflammatory genes increases inflammation. This phenomenon is of crucial importance in patients with chronic kidney disease (CKD), because atherosclerosis is one of the critical factors of their cardiovascular disease (CVD) and increased mortality. The effect of ROS disrupts the excretory function of each section of the nephron. It prevents the maintenance of intra-systemic homeostasis and leads to the accumulation of metabolic products. Renal regulatory mechanisms, such as tubular glomerular feedback, myogenic reflex in the supplying arteriole, and the renin–angiotensin–aldosterone system, are also affected. It makes it impossible for the kidney to compensate for water–electrolyte and acid–base disturbances, which progress further in the mechanism of positive feedback, leading to a further intensification of oxidative stress. As a result, the progression of CKD is observed, with a spectrum of complications such as malnutrition, calcium phosphate abnormalities, atherosclerosis, and anemia. This review aimed to show the role of oxidative stress and inflammation in renal impairment, with a particular emphasis on its influence on the most common disturbances that accompany CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–244 of 244
Richard, M. J., Ducros, V., Rorêt, M., Arnaud, J., Coudray, C., Fussellier, M., & Favier, A. E. (1993) · Biological Trace Element Research · doi:10.1007/bf02783185 · Cited by 46
Thiocyanate catalyzes myeloperoxidase-initiated lipid oxidation in LDL
Exner, M., Hermann, M., Hofbauer, R., Hartmann, B. W., Kapiotis, S., & Gmeiner, B. M. K. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.039 · Cited by 46
Protein stability of mitochondrial superoxide dismutase SOD2 is regulated by USP36
Kim, M., Ramakrishna, S., Lim, K., Kim, J., & Baek, K. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22940 · Cited by 43
Bonan, N. B., Steiner, T. M., Kuntsevich, V. I., Virzì, G. M., de Azevedo, M. L. V., Nakao, L. S., Barreto, F. C., Ronco, C., Thijssen, S., Kotanko, P., et al. (2016) · Blood Purification · doi:10.1159/000443784 · Cited by 43
Formanowicz, D., Radom, M., Rybarczyk, A., & Formanowicz, P. (2018) · Biosystems · doi:10.1016/j.biosystems.2018.01.002 · Cited by 43
Self-citationMyeloperoxidase in Chronic Kidney Disease
Rao, A. M., Anand, U., & Anand, C. V. (2010) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-010-0075-1 · Cited by 42
Malindretos, P., Sarafidis, P. A., Rudenco, I., Raptis, V., Makedou, K., Makedou, A., & Grekas, D. M. (2007) · American Journal of Nephrology · doi:10.1159/000107928 · Cited by 41
Eftekhari, M. H., Akbarzadeh, M., Dabbaghmanesh, M. H., & Hassanzadeh, J. (2014) · PubMed Central · Cited by 40
Leptin and chronic kidney diseases
Mao, S., Li, F., Liu, F., Jiang, S., Wu, L., & Zhang, J. (2018) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2018.1431278 · Cited by 40
Toblli, E., Cao, G., Oliveri, L. M., & Angerosa, M. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1296218 · Cited by 39
Fibroblast Growth Factor-23—A Potential Uremic Toxin
Kuczera, P., Adamczak, M., & Więcek, A. (2016) · Toxins · doi:10.3390/toxins8120369 · Cited by 39
Chronic kidney disease, heart failure and anemia
Virani, S., Khosla, A., & Levin, A. (2008) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(08)71026-2 · Cited by 38
Dyspepsia and gastric emptying in end-stage renal disease patients on hemodialysis
Salles, L. D., Santos, P. R., dos Santos, A. A., & de Souza, M. H. L. P. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-275 · Cited by 36
Zachara, B., Gromadzińska, J., Zbróg, Z., Swiech, R., Wąsowicz, W., Twardowska, E., Jabłońska, E., & Sobala, W. (2009) · Acta Biochimica Polonica · doi:10.18388/abp.2009_2531 · Cited by 36
Iron and Oxidative Stress in Renal Insufficiency
Lim, C. S., & Vaziri, N. D. (2004) · American Journal of Nephrology · doi:10.1159/000082201 · Cited by 34
Luo, J., Liang, A., Liang, M., Xia, R., Rizvi, Y. Q., Wang, Y., & Cheng, J. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015080867 · Cited by 34
Zhang, J., Wang, Z., Zhang, J., Zhu, L., Gao, X., & Chen, S. (2014) · PubMed Central · doi:10.3969/j.issn.1671-5411.2014.02.003 · Cited by 33
Chung, A. W. Y., Yang, H. H. C., Kim, J. M., Sigrist, M. K., Brin, G., Chum, E., Gourlay, W. A., & Levin, A. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq202 · Cited by 32
Nakatani, S., Yasukawa, K., Ishimura, E., Nakatani, A., Toi, N., Uedono, H., Tsuda, A., Yamada, S., Ikeda, H., Mori, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35177-x · Cited by 32
Montazerifar, F., Hashemi, M. M., Karajibani, M., & Dikshit, M. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2010.1074 · Cited by 31
Shen, H., Xu, Y., Lu, J., Ma, C., Zhou, Y., Li, Q., Chen, X., Zhu, A., & Shen, G. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0358-8 · Cited by 30
Toblli, J. E., Cao, G., Giani, J. F., Dominici, F. P., & Angerosa, M. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s132612 · Cited by 30
Łuczak, M., Suszyńska-Zajczyk, J., Marczak, Ł., Formanowicz, D., Pawliczak, E., Wanic-Kossowska, M., & Stobiecki, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050631 · Cited by 29
Self-citationLiu, Q., Yu, L., Feng, J.-H., Sun, Q., Li, S., & Jianming, Y. (2019) · Disease Markers · doi:10.1155/2019/6468729 · Cited by 29
Formanowicz, D., Gutowska, K., & Formanowicz, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113476 · Cited by 28
Self-citationPolymorphisms of Antioxidant Genes as a Target for Diabetes Management.
Tabatabaei‐Malazy, O., Khodaeian, M., Bitarafan, F., Larijani, B. A., & Amoli, M. M. (2017) · PubMed Central · doi:10.22088/acadpub.bums.6.3.135 · Cited by 27
Chang, K., Lee, A., Chen, W., Lin, Y., Hsu, J., Chan, H., Chang, C., Chang, S., Pan, C.-C., Sawamura, T., et al. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.03.016 · Cited by 23
Miric, D. J., Kisić, B., Stolic, R. V., Mirić, B., Mitić, R., & Janićijević-Hudomal, S. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/245253 · Cited by 23
Sinha‐Hikim, I., Shen, R., Lee, W.-N. N. P., Crum, A., Vaziri, N. D., & Norris, K. C. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00434.2009 · Cited by 23
Rasool, M., Ashraf, M. A. B., Malik, A., Waquar, S., Khan, S. A., Qazi, M. H., Ahmad, W., Asif, M., Khan, S. U., Zaheer, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171561 · Cited by 23
Santhanam, A. V. R., d’Uscio, L. V., & Katušić, Z. S. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12824 · Cited by 22
Khalil, S. K. M., Amer, H. A., EL-Behairy, A. M., & Warda, M. (2016) · Journal of Advanced Research · doi:10.1016/j.jare.2016.02.004 · Cited by 22
Jin, K., & Vaziri, N. D. (2013) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0851-3 · Cited by 21
Jaqueto, M., Delfino, V. D. A., Bortolasci, C. C., Barbosa, D. S., Morimoto, H. K., Frange, R. F. N., Ferreira, L. F. F., & Guimarães, F. B. D. S. (2016) · Brazilian Journal of Nephrology · doi:10.5935/0101-2800.20160045 · Cited by 21
Filler, G., Taheri, S., McIntyre, C. W., Smith, C., Subramanian, L., Fusch, G., & Fusch, C. (2017) · Clinical Kidney Journal · doi:10.1093/ckj/sfx115 · Cited by 17
The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients
de Oliveira, R. B., Liabeuf, S., Okazaki, H., et al. (2013) · Clinical Kidney Journal · doi:10.1093/ckj/sfs176 · Cited by 16
Krueger, K., Shen, J., Maier, A., Tepel, M., & Scholze, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7423249 · Cited by 16
Savić, J. Ž., Zeljković, A., Bogavac‐Stanojević, N., Simić‐Ogrizović, S., Kravljača, M., Stošović, M., Vekić, J., Spasojević‐Kalimanovska, V., Jelić‐Ivanović, Z., Gojković, T., et al. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.928944 · Cited by 15
Caimi, G., Carollo, C., Montana, M., Vaccaro, F., & Presti, R. L. (2009) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-2009-1237 · Cited by 14
Lipoprotein glycation in atherogenesis
Younis, N. N., Soran, H., Sharma, R., Charlton-Menys, V., & Durrington, P. N. (2009) · Clinical Lipidology · doi:10.2217/clp.09.61 · Cited by 14
Toblli, J. E., Cao, G., Giani, J., Dominici, F. P., & Angerosa, M. (2014) · Drug Research · doi:10.1055/s-0034-1384534 · Cited by 13
Maruyama, Y., Yokoyama, K., Yamamoto, H., et al. (2012) · Clinical Nephrology · doi:10.5414/cn107424 · Cited by 11
Gryszczyńska, B., Budzyń, M., Formanowicz, D., Wanic-Kossowska, M., Formanowicz, P., Majewski, W., Iskra, M., & Kasprzak, M. P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051416 · Cited by 11
Self-citationCalcium Metabolism and Kidney Disease
BINSWANGER, U. (1974) · Springer eBooks · doi:10.1007/978-3-642-65746-7_4 · Cited by 5
Cited by
Ten things to know about ten cardiovascular disease risk factors
Bays, H. E., Taub, P. R., Epstein, E., Michos, E. D., Ferraro, R. A., Bailey, A. L., Kelli, H. M., Ferdinand, K. C., Echols, M. R., Weintraub, H., et al. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100149 · Cited by 274
Grishanova, A. Y., & Perepechaeva, M. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126719 · Cited by 130
Metadata
- Authors
- Podkowińska, A., & Formanowicz, D.
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2020-08-14
- Volume
- 9
- Issue
- 8
- Pages
- 752
- ISSN
- 2076-3921 (ISSN-L)
- OpenAlex
- W3049004220
- Cited by
- 356
- References
- 244
- FWCI
- 20.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.